Abiopharma

New Form 424B2 - DEUTSCHE BANK AKTIENGESELLSCHAFT <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005922 <b>Size:</b> 208 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010221 <b>Size:</b> 871 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001140361-26-015518 <b>Size:</b> 319 KB

Psyence BioMed Positioned as Worlds only Licensed Pharmaceutical Grade Ibogaine Supplier at Source

Bharucha Kaizad 🟡 adjusted position in 0 shares (1 derivative) of HDFC BANK LTD (HDB) at $6.80 Transaction Date: Apr 17, 2026 | Filing ID: 162728

NLS PHARMACEUTICS LTD. (NCEL) Files Form 6-K

Bonus Issue/ Capitalisation Issue :

New Form 3 - PS International Group Ltd. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001213900-26-045410 <b>Size:</b> 3 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010220 <b>Size:</b> 677 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005921 <b>Size:</b> 334 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010219 <b>Size:</b> 865 KB

(75% Positive) FERMI INC. (FRMI) Announces Business Combination

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

New Form 13F-HR - First Bancorp, Inc /ME/ <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000765207-26-000072 <b>Size:</b> 92 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005920 <b>Size:</b> 271 KB